ARISTADA (Alkermes, Inc.)
Welcome to the PulseAid listing for the ARISTADA drug offered from Alkermes, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alkermes, Inc. |
| NON-PROPRIETARY NAME: | aripiprazole lauroxil |
| SUBSTANCE NAME: | ARIPIPRAZOLE LAUROXIL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, SUSPENSION, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-10-05 |
| END MARKETING DATE: | 0000-00-00 |
ARISTADA HUMAN PRESCRIPTION DRUG Details:
| Item Description | ARISTADA from Alkermes, Inc. |
| LABELER NAME: | Alkermes, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 441(mg/1.6mL) |
| START MARKETING DATE: | 2015-10-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 65757-401_6346fbb7-8257-4b61-9301-3eb408a17646 |
| PRODUCT NDC: | 65757-401 |
| APPLICATION NUMBER: | NDA207533 |
Other ARIPIPRAZOLE LAUROXIL Pharmaceutical Manufacturers / Labelers:
